Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 619

The DOI matches its Crossref record; 192 of the 192 references it cites were found in a registry or an index.

The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases

Open access
Griesenauer, Brad, Paczesny, Sophie·2017·Frontiers in Immunology

Abstract

Il1rl1 (also known as ST2) is a member of the IL-1 superfamily, and its only known ligand is IL-33. ST2 exists in two forms as splice variants: a soluble form (sST2), which acts as a decoy receptor, sequesters free IL-33, and does not signal, and a membrane-bound form (ST2), which activates the MyD88/NF-κB signaling pathway to enhance mast cell, Th2, regulatory T cell (Treg), and innate lymphoid cell type 2 functions. sST2 levels are increased in patients with active inflammatory bowel disease, acute cardiac and small bowel transplant allograft rejection, colon and gastric cancers, gut mucosal damage during viral infection, pulmonary disease, heart disease, and graft-versus-host disease. Recently, sST2 has been shown to be secreted by intestinal pro-inflammatory T cells during gut inflammation; on the contrary, protective ST2-expressing Tregs are decreased, implicating that ST2/IL-33 signaling may play an important role in intestinal disease. This review will focus on what is known on its signaling during various inflammatory disease states and highlight potential avenues to intervene in ST2/IL-33 signaling as treatment options.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2017.00475

Cites

192 of 192 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 192 references

Research works printed but not linked: 10

  1. Tominaga, 2016, Soluble form of the ST2 gene product exhibits growth promoting activity in NIH-3T3 cells, Biochem Biophys Rep, 5, 8, 10.1016/j.bbrep.2015.11.020 · doi:10.1016/j.bbrep.2015.11.020
  2. Caselli, 2014, Inflammation in cardiac disease: focus on Interleukin-33/ST2 pathway, Inflamm Cell Signal, 1, e149, 10.14800/ics.149 · doi:10.14800/ics.149
  3. Diaz-Jimenez, 2011, Soluble ST2: a new and promising activity marker in ulcerative colitis, World J Gastroenterol, 17, 2181, 10.3748/wjg.v17.i17.2181 · doi:10.3748/wjg.v17.i17.2181
  4. McDonald, 2015, Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment, Blood, 126, 113, 10.1182/blood-2015-03-636753 · doi:10.1182/blood-2015-03-636753
  5. Abu Zaid, 2017, Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT, Blood, 129, 162, 10.1182/blood-2016-08-735324 · doi:10.1182/blood-2016-08-735324
  6. Mathews, 2016, Elevated ST2 distinguishes incidences of pediatric heart and small bowel transplant rejection, Am J Transplant, 16, 938, 10.1111/ajt.13542 · doi:10.1111/ajt.13542
  7. Lin, 2016, Distribution and clinical association of plasma soluble ST2 during the development of type 2 diabetes, Diabetes Res Clin Pract, 118, 140, 10.1016/j.diabres.2016.06.006 · doi:10.1016/j.diabres.2016.06.006
  8. Thomassen, 1995, Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue, Cell Growth Differ, 6, 179
  9. Na, 2012, IL-33 enhances Siglec-8 mediated apoptosis of human eosinophils, Cytokine, 57, 169, 10.1016/j.cyto.2011.10.007 · doi:10.1016/j.cyto.2011.10.007
  10. Seo, 2016, Biomarkers for idiopathic pneumonia syndrome (IPS) after hematopoietic cell transplantation (HCT): comparison with viral infectious pneumonia, Biol Blood Marrow Transplant, 22, S73, 10.1016/j.bbmt.2015.11.366 · doi:10.1016/j.bbmt.2015.11.366

Cited by

See all 619

Metadata

Authors
Griesenauer, B., & Paczesny, S.
Venue
Frontiers in Immunology
Published
2017-04-24
Volume
8
Pages
475-475
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2609744794
Cited by
619
References
192
FWCI
18.84
Type
journal article
Language
en
Open access
gold
Funders
  • National Cancer Institute (R01CA168814)
  • National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007519)
  • Leukemia and Lymphoma Society (1293-15)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases. https://app.cochat.ai/papers/10.3389/fimmu.2017.00475
The paper
Griesenauer, B., & Paczesny, S. (2017). The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2017.00475

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.